High expression of a CD38-like molecule in normal prostatic epithelium and its differential loss in benign and malignant disease.

Kramer, G; Steiner, G; Födinger, D; Fiebiger, E; Rappersberger, C; Binder, S; Hofbauer, J; Marberger, M · J Urol · 1995

case_control · Level III

Where this comes from

Abstract

We characterize an undescribed antigen on prostatic epithelial cells, which is recognized by anti-CD38. Normal (3 cases), benign hyperplastic (10) and carcinomatous (10) prostatic tissues were analyzed using immunohistochemistry, immuno-electron microscopy and the Western blot test. Comparison of prostatic and lymphatic CD38 antigen revealed identical bands at 45 kD. Electron microscopy demonstrated anti-CD38 reactivity on the cytoplasmic membrane and within the secretory vacuoles. Double labeling with anti-cytokeratin types 5/15 and 8/18 confirmed that basal and secretory normal prostatic epithelial cells express CD38. By contrast, a complete loss was found in malignant (52.8%), tumor-surrounding nonmalignant (16.3%) and benign prostatic hyperplasia derived glands (3.7%). CD38 is a novel prostatic antigen. Its role in intracellular calcium mobilization may contribute to smooth muscle cell contraction and/or sperm motility.

Medical subject headings